Analysis of hepatitis C virus isolates using molecular and serological typing methods

Acta Virologica

Volumn 41, Issue 5, 1997, Pages 269-275

  Cretel, E ^a   Gallian, P ^a,b   Obadia, Y ^b   Rousseau, S ^c   De Micco, P ^a   De Lamballerie, X ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^c Dir des Interventions S   (France)

Author keywords

Diagnosis; Genotype; Hepatitis C virus; Polymerase chain reaction; Serology

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRISONER; SEROTYPING; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS TYPING;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; POLYMERASE CHAIN REACTION; PRISONERS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SEROTYPING; SUBSTANCE-RELATED DISORDERS;

EID: 0031464785     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, El-Zayadi AR, Kew MC, Conradie J, Lin CK, Marsden H, Saeed AA, Parker D, Yap PL, Simmonds P (1995): Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J. Gen. Virol. 76, 1737-1748.
2. Cuthbert JA (1994): Hepatitis C: Progress and Problems. Clin.. Microbiol. Rev. 7, 505-532.
3. de Lamballerie X (1996a): Serological and molecular biology screening techniques for HCV infection. Nephrol. Dial. Transplant. 11, 9-11.
4. de Lamballerie X, Olmer M, Bouchouareb M, Zandotti C, De Micco Ph (1996b): Nosocomial transmission of hepatitis C virus in haemodialysis patients. J. Med. Virol. 49, 296-302.
5. de Lamballerie X, Charrel RN, Attoui H, De Micco Ph (1997): Classification of hepatitis C virus variants in 6 major types based on the envelope 1 and nonstructural 5B regions and complete polyprotein sequences analysis. J. Gen. Virol. 78, 45-51.
6. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P (1994): Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19, 13-18.
7. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, Okamoto H, Bismuth H, Brechot C (1995): Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108, 1088-1096.
8. Fretz C, Jeannel D, Stuyver L, Herve V, Lunel F, Boudifa A, Mathiot C, de The G, Fournel JJ (1995): HCV infection in a rural population of the Central African Republic: evidence for three additional subtypes of genotype 4. J. Med. Virol. 47, 435-437
9. Garson JA, Clewley JP, Simmonds P, Zhang LQ, Mori J, Ring C, Follett EA, Dow BC, Martin S, Gunson H (1992): Hepatitis C viraemia in United Kingdom blood donors. A multicentre study. Vox Sang. 62, 218-223.
10. Giannini C, Thiers X Nousbaum J-B, Stuyver L, Maertens G, Brechot C (1995): Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J. Hepatol. 23, 246-253.
11. Hawkins A, Davidson F, Simmonds P (1997); Comparison of plasma virus load amongst individuals infected with hepatitis C virus genotypes 1,2, and 3 using Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor and an in-house limiting dilution method. J. Clin. Microbiol. 35, 187-192.
12. Hino K, Sainokami S, Shimoda K, Lino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi, M (1994): Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J. Med. Virol. 42, 299-305.
13. Kanai K, Kako M, Okamoto H (1992): HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339, 1543.
14. Kato N, Hujikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimtohno K (1990): Molecular cloning of the human hepatitis C virus genome from Japanese patients with non A non B hepatitis. Proc. Natl. Acad. Sci. USA 87, 9524-9528.
15. Lai ME, Mazzoleni AP, Farci P, Melis A, Porru A, Orgiana G, Arnone M, Balestrieri A (1993): Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels. J. Med. Virol. 41, 282-288.
16. Lau JY, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian KP, Kohara M, Simmonds P, Urdea MS. (1995): Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J. Infect. Dis. 171, 281-289.
17. Nagata S, Ishii H, Yokoyama H, Kato S, Moriya S, Maruyama K, Takahashi H, Tsuchiya M (1994): Influence of HCV infection and its subtypes on clinical course of alcoholic liver disease. Gastroenterol. Jpn. 28, 91-94.
18. Okamoto H, Sujiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y (1992): Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73, 673-682.
19. Pawlotsky JM, Roudot-Thoradal F, Bastie A, Pellet C, Duval J, Dhumeaux D (1996): Are hepatitis C virus genotypes 1a and 1b so different? Hepatology 23, 1289-1291
20. Pawlotsky JM, Prescott L, Simmonds P, Pellet C, Laurent-Puig P, Labonne C, Darthuy F, Remire J, Duval J, Buffet C, Etienne JP, Dhumeaux D, Dussaix E (1997): Serological determination of hepatitis C genotype: Comparison with a standardized genotyping assay. J. Clin. Microbiol. (in press).
21. Pozatto G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, Kaneko S, Unoura M, Kobayashi K (1991): Severity of liver disease with different hepatitis C viral clones. Lancet 338, 509.
22. Pozzato G, Kaneko S, Moretti M, Croce LS, Franzin F, Unoura M, Bereich L, Tiribelli C, Crovatto M, Santini G, Kobayashi K (1994): Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J. Med. Virol. 43, 291-296.
23. Pozzato G, Moretti M, Croce LS, Sasso F, Kaneko S, Unoura M, Kobayashi K, Crovatto M, Santini G, Tiribelli C (1995): Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains. J. Med. Virol. 45, 445-450.
24. Qu D, Li JS, Vitvitski L, Mechai S, Berby F, Tong SP, Bailly F, Wang QS, Martin JL, Trepo C (1994): Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II. Hepatology 21, 70-75.
25. Ravaggi A, Primi D, Cariani E (1992): Direct amplification of HCV RNA from human serum. PCR Meth. Appl 1, 291-292.
26. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kup G (1990): Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87, 6547-6549.
27. Sheu JC, Wang JT, Wang TH, Wang CY, Yang PM, Huang GT, Shin LN, Lee HS, Chen DS (1993): Prevalence of hepatitis C viral infection in a community in Taiwan. Detection by synthetic peptide-based assay and polymerase chain reaction. J. Hepatol. 17, 192-198.
28. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, Brugnetti B, Civardi E, Salvaneschi L, Mondelli M. (1995): Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21, 285-290.
29. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follett EA, Yap PL, Marsden H (1993): Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J. Clin. Microbiol. 31, 1493-1503.
30. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechet C, Brouwer JT, Chan S-W, Chayama K, Chen D-S, Choo Q-L, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadzlyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trépo C, Weiner A, Yap PL, Urdea MS (1994): A P roposed System for the Nomenclature of Hepatitis C Viral Genotypes. Hepatology 19, 1321-1324.
31. Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes EC, Smith DB (1996): Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J. Gen. Virol. 77, 3013-3024.
32. Stern M, Manny N, Klein A, Naparstek Y, Shraga S, Tur-Kaspa R (1995): A study of Israeli blood donors, asymptomatic carriers of hepatitis C virus, in relation to liver disease, cryoglobulinemia and transmission. Isr. J. Med. Sci. 3135, 277-279.
33. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G (1993): Typing of hepatitis C isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74, 1093-1102.
34. Takada N, Takase S, Enomoto N, Takada A, Date C (1992): Clinical backgrounds of the patients having different types of hepatitis C genomes. J. Hepatol. 14, 35-40.
35. Takada N, Takase S, Takada A (1993): Effect of genotypes of hepatitis C virus on Interferon treatment for chronic hepatitis C hepatitis. Gastroenterol. Jpn. 28, 268-275.
36. Tawaraya T, Ohkoshi S, Kuwana K, Watanabe M, Kamimura T, Asakura H (1995): Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. J. Med. Virol. 45, 367-372.
37. Telfer PT, Devereux H, Savage K, Scott F, P. Dhillon AP, Dusheiko G, Lee CA (1995): Chronic hepatitis C virus infection in haemophilic patients: clinical significance of viral genotype Thromb. Haemostasis 74, 1259-1264.
38. Tsubota A, Chayama K, Arase Y, Koida I, Saitoh S, Ikeda K, Iwasaki S, Matsumoto T, Kobayashi M, Kumada H (1993): Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J. Gastroenterol. Hepatol. 8, 535-539.
39. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K (1994): Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19, 1088-1094.
40. Van Doom L-J, Kleter B, Pike I, Quint W (1996): Analysis of hepatitis C virus isolates by serotyping and genotyping. J. Clin.. Microbiol. 34, 1784-1787.
41. Van Doom L-J, Kleter B, Stuyver L, Maertens G, Brouwer H, Schalm S, Heijtink R, Quint W (1994): Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles. J. Hepatol. 21, 122-129.
42. Wu JS, Lu CF, Chou WH, Chen HY, Lee HF, Wu YC, Lin SY (1992): High prevalence of hepatitis C virus infection in aborigines in Taiwan. Jpn. J. Med. Sci. Biol. 45, 165-174.
43. Wu RR, Mizokami M, Lau JY, Ohno T, Fang ZX, Ohba K, Wu XS, Hata A, Sasaki M, Iino S (1995): Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J. Med. Virol. 45, 174-178.
44. Xu LZ, Larzul D, Delaporte E, Brechet C, Kremsdorf D (1994): Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J. Gen. Virol. 75, 2393-2398.
45. Yamada G, Takahashi M, Miyamoto R, Tsuji T, Yoshizawa H, Okamoto H (1994): Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV RNA. Dig. Dis. Sci. 39, 441-444.
46. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T (1992): Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16, 293-299.
47. Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Kasahara A, Fusamoto H, Ohtani S, Okubo Y, Kamada T (1994): Hepatitis C virus antibodies and virus replication in asymptomatic blood donors. Vox Sang. 67, 280-285.